78 related articles for article (PubMed ID: 23297089)
21. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
22. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta receptor expression and smad2 localization are cell density dependent in fibroblasts.
Petridou S; Maltseva O; Spanakis S; Masur SK
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):89-95. PubMed ID: 10634606
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
Wang Y; Lui WY
Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
[TBL] [Abstract][Full Text] [Related]
25. Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma.
Vehviläinen P; Koli K; Myllärniemi M; Lindholm P; Soini Y; Salmenkivi K; Kinnula VL; Keski-Oja J
Hum Pathol; 2011 Feb; 42(2):269-78. PubMed ID: 21106222
[TBL] [Abstract][Full Text] [Related]
26. Expression of integrin subunit beta1B in integrin beta1-deficient GD25 cells does not interfere with alphaVbeta3 functions.
Armulik A; Svineng G; Wennerberg K; Fässler R; Johansson S
Exp Cell Res; 2000 Jan; 254(1):55-63. PubMed ID: 10623465
[TBL] [Abstract][Full Text] [Related]
27. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
Deng X; Bellis S; Yan Z; Friedman E
Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor beta2, but not beta1 and beta3, is critical for early rat lung branching.
Liu J; Tseu I; Wang J; Tanswell K; Post M
Dev Dyn; 2000 Apr; 217(4):343-60. PubMed ID: 10767079
[TBL] [Abstract][Full Text] [Related]
29. Human eosinophils have an intact Smad signaling pathway leading to a major transforming growth factor-beta target gene expression.
Kanzaki M; Shibagaki N; Hatsushika K; Mitsui H; Inozume T; Okamoto A; Dobashi Y; Ogawa H; Shimada S; Nakao A
Int Arch Allergy Immunol; 2007; 142(4):309-17. PubMed ID: 17135762
[TBL] [Abstract][Full Text] [Related]
30. Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2.
Choi S; Kim Y; Park H; Han IO; Chung E; Lee SY; Kim YB; Lee JW; Oh ES; Yi JY
Biochem Biophys Res Commun; 2009 Jun; 384(2):231-5. PubMed ID: 19394307
[TBL] [Abstract][Full Text] [Related]
31. β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner.
Schooley AM; Andrews NM; Zhao H; Addison CL
Cancer Lett; 2012 Mar; 316(2):157-67. PubMed ID: 22099877
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta down-regulates IL-6 signaling in intestinal epithelial cells: critical role of SMAD-2.
Walia B; Wang L; Merlin D; Sitaraman SV
FASEB J; 2003 Nov; 17(14):2130-2. PubMed ID: 14500551
[TBL] [Abstract][Full Text] [Related]
33. Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics.
Garamszegi N; Garamszegi SP; Samavarchi-Tehrani P; Walford E; Schneiderbauer MM; Wrana JL; Scully SP
Oncogene; 2010 Apr; 29(16):2368-80. PubMed ID: 20101206
[TBL] [Abstract][Full Text] [Related]
34. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
[TBL] [Abstract][Full Text] [Related]
35. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
36. Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration.
Guo HB; Lee I; Kamar M; Akiyama SK; Pierce M
Cancer Res; 2002 Dec; 62(23):6837-45. PubMed ID: 12460896
[TBL] [Abstract][Full Text] [Related]
37. Effect of TGF-β on ocular surface epithelial cells.
Benito MJ; Calder V; Corrales RM; García-Vázquez C; Narayanan S; Herreras JM; Stern ME; Calonge M; Enríquez-de-Salamanca A
Exp Eye Res; 2013 Feb; 107():88-100. PubMed ID: 23220729
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
39. Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases.
Lim HC; Couchman JR
Biochim Biophys Acta; 2014 Aug; 1840(8):2482-90. PubMed ID: 24447566
[TBL] [Abstract][Full Text] [Related]
40. The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin.
Kwon MJ; Kim Y; Choi Y; Kim SH; Park S; Han I; Kang DH; Oh ES
Biochem Biophys Res Commun; 2013 Feb; 431(3):415-20. PubMed ID: 23333331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
